Instruction for use: Solu-Decortin H25

Active substance Prednisolon

ATX Code H02AB06 Prednisolon

Pharmacological group

Glucocorticosteroids

Nosological classification (ICD-10)

B99 Other infectious diseases

Infections (opportunistic), Infections on the background of immunodeficiency, Opportunistic infections

E27.4 Other and unspecified adrenocortical insufficiency

Hypocorticism, Hypoaldosteronism, Adrenal insufficiency, Insufficiency of the adrenal cortex, Insufficiency of the adrenal cortex, Secondary adrenocortical insufficiency, Secondary adrenal insufficiency, Secondary insufficiency of the adrenal cortex, Temporary decrease in the function of the adrenal cortex, Dysfunction of the adrenal cortex

G93.6 Edema of the brain

Intraoperative cerebral edema, Cerebral edema, Post-traumatic swelling of the brain, Brain edema associated with radiation therapy, Brain edema associated with head trauma, Post-traumatic cerebral edema, Edema of the brain in poisoning

J81 Pulmonary edema

Alveolar pulmonary edema, Pulmonary edema, Swelling of the lung, Toxic pulmonary edema, Shock lung, Acute pulmonary edema

R57.0 Cardiogenic shock

cardiogenic shock

R57.1 Hypovolemic shock

Hypovolemic shock during surgery, Acute hypovolemia

T78.2 Anaphylactic shock, unspecified

Anaphylactic shock, Anaphylactoid reaction, Anaphylactic shock, Anaphylactic reactions, Anaphylactic shock to drugs

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

T79.4 Traumatic shock

Hemorrhagic shock, Crush syndrome, hemorrhagic shock, postoperative shock, post-traumatic shock, traumatic shock, hemorrhagic shock and encephalopathy syndrome

T81.1 Shock during or after the procedure, not elsewhere classified

Operating shock, Postoperative shock, Operational shock

T86 Dying and rejection of transplanted organs and tissues

Graft versus host disease, The rejection crisis in organ and tissue transplantation, The crisis of immunological incompatibility in organ transplantation, Incompatibility of tissues, Graft rejection, Rejection reactions during tissue transplantation, Graft versus host response, Transplant rejection reaction, Graft-versus-host syndrome, Fabric incompatibility

Y84.3 Abnormal reaction or late complication in a patient without mention of accidental harm to him during the shock therapy

Composition and form of release

1 bottle with powder for the preparation of the injectable solution contains prednisolone hemisuccinate 25, 50 or 250 mg, complete with a solvent in 10 ml ampoules; In the package 1 or 3 pcs.

pharmachologic effect

Pharmacological action - anti-inflammatory, antiallergic, immunosuppressive.

Indications

Shock (anaphylactic, posttraumatic, posthemorrhagic, cardiogenic, due to exhaustion or hypothermia), severe allergic and anaphylactic reactions, toxic pulmonary edema, cerebral edema, transplant rejection, acute severe dermatoses, acute blood diseases, severe infectious diseases (in combination with antibiotics), Acute insufficiency of the adrenal cortex.

Contraindications

Peptic ulcer of the stomach and duodenum, osteoporosis, acute viral infections, poliomyelitis, systemic mycoses.

Side effects

Myasthenia gravis, osteoporosis, visual impairment, depression, hypertension, hypercoagulation, thrombosis, hypokalemia, hyperglycemia.

Dosing and Administration

In / in slowly, with shock - 250-500 mg, in exceptional cases - 500-1000 mg. After relief of acute phenomena - oral intake of prednisolone.

storage Conditions

In the dark place.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiry date printed on the package.